Biotech Industry Expected to Experience More M&A Activity in 2013

Five Star Equities Provides Stock Research on Amicus Therapeutics and Zalicus

Continue Reading

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS

Continue Reading

Weaker-Than-Expected Demand for iPhone 5 Causes Apple to Slash Orders for iPhone Parts

Research Driven Investing Provides Stocks Research on Avago and RF Micro Devices

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and Halozyme Therapeutics

Continue Reading

Over the Next 5 Years Global Coal Demand to Increase at an Average of 2.6% a Year

The Paragon Report Provides Stock Research on Cloud Peak Energy and Walter Energy

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Keryx Biopharmaceuticals and Novavax

Continue Reading

Natural Gas Futures Have Fallen Nearly 20 Percent From 12-Month High in November

Five Star Equities Provides Stock Research on Apache and Linn Energy

Continue Reading

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on AEterna Zentaris and BioCryst Pharmaceuticals

Continue Reading

Margin Between U.S. and Europe Oil Benchmarks Narrowest in Over Three-Months

The Paragon Report Provides Stock Research on Swift Energy and ZaZa Energy

Continue Reading

By 2017 Coal Projected to Rival Oil as World-s Top Energy Source

The Paragon Report Provides Stock Research on CONSOL Energy Inc. and Natural Resource Partners LP

Continue Reading